Aquestive Therapeutics Inc
Statements
Ratios
Valuation ratios (P/E, P/S, EV/EBITDA and the other multiples) are based on the closing price at the end of each period, not on the current price. Margins and returns are shown in percent, multiples without a unit, per-share figures in the reporting currency, net debt in millions.
Tick rows to compare them in a chart (up to 4)
| Line item | Q2 07 | Q4 16 | Q1 17 | Q2 17 | Q3 17 | Q4 17 | Q1 18 | Q2 18 | Q3 18 | Q4 18 | Q1 19 | Q2 19 | Q3 19 | Q4 19 | Q1 20 | Q2 20 | Q3 20 | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Valuation | ||||||||||||||||||||||||||||||||||||||||
| – | – | – | – | – | – | – | – | 6.6 | 2.3 | 3.0 | 1.9 | 1.5 | 2.9 | 1.5 | 2.8 | 3.0 | 4.0 | 3.8 | 3.5 | 3.7 | 3.1 | 2.1 | 0.6 | 1.3 | 1.0 | 1.7 | 2.1 | 2.0 | 2.7 | 6.1 | 4.1 | 7.7 | 5.7 | 5.1 | 7.4 | 14.3 | 17.8 | 10.2 | 9.7 | |
| – | – | – | – | – | – | – | – | 17.7 | 15.6 | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | 6.3 | 2.1 | 3.2 | 2.4 | 2.2 | 3.1 | 2.0 | 3.4 | 3.8 | 4.1 | 4.1 | 3.7 | 3.9 | 3.6 | 2.9 | 1.3 | 2.1 | 1.6 | 2.1 | 2.5 | 2.3 | 2.8 | 4.9 | 3.0 | 6.9 | 5.0 | 4.5 | 6.9 | 12.2 | 16.0 | 8.8 | 8.8 | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 120.1 | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 7.3 | 10.2 | 16.2 | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | -4.6% | -9.4% | -19.4% | -48.2% | -66.8% | -39.7% | -76.6% | -30.0% | -26.0% | -25.2% | -25.1% | -25.8% | -22.6% | -21.5% | -31.8% | -136.0% | -45.7% | -25.2% | 13.7% | 9.8% | 6.2% | -5.4% | -8.4% | -10.5% | -7.5% | -10.9% | -17.7% | -15.3% | -8.2% | -6.7% | -8.6% | -8.8% | |
| Margins | ||||||||||||||||||||||||||||||||||||||||
| – | – | – | – | 71.3% | 70.4% | 71.2% | 72.5% | 65.3% | 68.9% | 66.7% | 64.2% | 65.4% | 61.3% | 57.9% | 68.6% | 69.2% | 71.7% | 75.0% | 69.0% | 69.3% | 70.5% | 68.4% | 65.5% | 63.7% | 59.3% | 57.2% | 54.2% | 55.4% | 58.8% | 60.2% | 68.5% | 69.4% | 69.0% | 68.4% | 61.1% | 60.3% | 58.3% | 63.5% | 67.0% | |
| – | – | – | – | 5.9% | -0.2% | 6.0% | -31.6% | -69.8% | -72.6% | -118.8% | -99.0% | -104.0% | -100.1% | -109.7% | -58.0% | -67.4% | -93.6% | -77.9% | -106.2% | -82.4% | -68.2% | -69.0% | -84.4% | -89.5% | -88.2% | -79.4% | -61.0% | -45.6% | -29.9% | -37.8% | -26.0% | -35.8% | -53.5% | -75.9% | -119.2% | -128.6% | -159.5% | -111.2% | -97.5% | |
| – | – | – | – | -10.2% | -13.4% | -4.6% | -44.3% | -91.5% | -91.0% | -141.5% | -119.2% | -127.4% | -125.9% | -139.6% | -84.2% | -87.2% | -121.7% | -111.9% | -152.7% | -132.1% | -138.8% | -132.9% | -146.3% | -147.7% | -114.1% | -71.2% | -48.6% | -25.2% | -15.6% | -55.9% | -44.1% | -59.8% | -76.7% | -100.0% | -147.4% | -158.9% | -188.1% | -137.1% | -144.6% | |
| – | – | – | – | – | 5.6% | 1.4% | 10.6% | -30.3% | -22.0% | -58.9% | -93.9% | -100.9% | -115.7% | -116.1% | -83.4% | -77.8% | -100.3% | -96.3% | -91.3% | -83.2% | -66.7% | -65.9% | -79.3% | -61.0% | -25.8% | 23.8% | 20.6% | 12.5% | -14.6% | -51.7% | -42.7% | -58.4% | -62.4% | -90.4% | -113.3% | -117.4% | -119.0% | -88.2% | -85.0% | |
| Returns | ||||||||||||||||||||||||||||||||||||||||
| – | – | – | – | – | – | – | – | -245.1% | -608.9% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | -20.7% | -7.3% | -85.3% | -63.9% | -70.7% | -118.0% | -127.3% | -138.4% | -84.4% | -105.5% | -78.5% | -95.3% | -88.7% | -87.1% | -95.6% | -94.9% | -113.8% | -122.2% | -129.7% | -137.0% | -95.3% | -54.0% | -39.7% | -20.4% | -13.7% | -22.2% | -21.9% | -32.0% | -43.5% | -53.1% | -69.4% | -42.2% | -52.2% | -48.8% | -59.2% | |
| Balance Sheet & Debt | ||||||||||||||||||||||||||||||||||||||||
| – | 68 | 48 | – | – | 28 | 29 | 36 | -17 | -13 | 7.7 | 25 | 39 | 11 | 26 | 37 | 46 | 5.8 | 11 | 5.8 | 10 | 26 | 40 | 37 | 35 | 25 | 16 | 17 | 15 | 4.0 | -66 | -59 | -46 | -39 | -34 | -25 | -91 | -82 | -70 | -47 | |
| – | – | – | – | – | 9.4 | 3.6 | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 3.4 | – | – | – | – | – | – | – | – | – | – | |
| -92.1% | -243.6% | – | – | – | -61.5% | -49.5% | -97.8% | 26.0% | 11.6% | -8.9% | -48.9% | -70.6% | -7.8% | -32.3% | -33.7% | -72.4% | -77.1% | -83.6% | -80.4% | -92.4% | -132.5% | -164.8% | -171.1% | -208.0% | -207.7% | -178.2% | -187.1% | -173.1% | -185.5% | -28.0% | -30.2% | -41.3% | -59.3% | -59.6% | -77.5% | -2.5% | -21.0% | -24.1% | -42.8% | |
| – | – | – | – | – | – | – | – | 2.0 | 4.7 | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| Per Share | ||||||||||||||||||||||||||||||||||||||||
| – | – | – | – | -0.54 | -0.45 | -0.17 | -1.42 | -2.43 | -2.46 | -3.21 | -2.57 | -2.70 | -2.51 | -2.03 | -1.49 | -1.43 | -1.65 | -1.52 | -1.73 | -1.58 | -1.75 | -1.67 | -1.61 | -1.33 | -1.00 | -0.45 | -0.39 | -0.19 | -0.11 | -0.39 | -0.28 | -0.39 | -0.48 | -0.57 | -0.65 | -0.62 | -0.69 | -0.56 | -0.63 | |
| – | – | – | – | 5.33 | 3.35 | 3.69 | 3.20 | 2.66 | 2.70 | 2.27 | 2.16 | 2.12 | 1.99 | 1.45 | 1.76 | 1.64 | 1.36 | 1.36 | 1.13 | 1.20 | 1.26 | 1.25 | 1.10 | 0.90 | 0.88 | 0.63 | 0.81 | 0.74 | 0.74 | 0.70 | 0.64 | 0.65 | 0.63 | 0.57 | 0.44 | 0.39 | 0.37 | 0.41 | 0.43 | |
| -1.35 | – | -0.88 | – | – | -1.32 | -1.14 | -1.62 | 0.99 | 0.40 | -0.24 | -0.99 | -1.38 | -0.23 | -0.62 | -0.64 | -1.09 | -1.43 | -1.46 | -1.45 | -1.54 | -2.03 | -2.25 | -2.12 | -2.02 | -2.18 | -1.48 | -1.86 | -1.59 | -1.55 | -0.49 | -0.39 | -0.50 | -0.66 | -0.64 | -0.73 | -0.04 | -0.28 | -0.28 | -0.45 | |
| – | – | – | – | – | 0.19 | 0.05 | 0.34 | -0.80 | -0.59 | -1.34 | -2.02 | -2.14 | -2.30 | -1.69 | -1.47 | -1.28 | -1.36 | -1.30 | -1.03 | -1.00 | -0.84 | -0.83 | -0.87 | -0.55 | -0.23 | 0.15 | 0.17 | 0.09 | -0.11 | -0.36 | -0.27 | -0.38 | -0.39 | -0.51 | -0.50 | -0.46 | -0.43 | -0.36 | -0.37 | |
Showing the most recent 40 periods — older statements are on file for this stock.
Data as of: October 8, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.